Structured evidence table for Fish Oil Dry Eye Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Fish Oil Dry Eye Randomized Trial | This shift is closely associated with the growing trend of pet humanization, whereby companion animals are increasingly regarded as family members and their diets are expected to support health, longevity, and quality of life in ways analogous to human nutrition [,]. | 3 | Vuthisopon Sujira (2026) | Advances in Functional Pet Food Research: Health-Driven Ingredients, Nutritional Targets and Evidence-Based Claims |
| Fish Oil Dry Eye Randomized Trial | At the same time, advances in processing technologies, including precision extrusion, encapsulation, and controlled-release systems, have improved the stability and delivery efficiency of functional compounds within complex pet food matrices []. | 3 | Vuthisopon Sujira (2026) | Advances in Functional Pet Food Research: Health-Driven Ingredients, Nutritional Targets and Evidence-Based Claims |
| Fish Oil Dry Eye Randomized Trial | The collected evidence was then organized thematically by health domain, product function, and translational relevance. | 3 | Vuthisopon Sujira (2026) | Advances in Functional Pet Food Research: Health-Driven Ingredients, Nutritional Targets and Evidence-Based Claims |
| Fish Oil Dry Eye Randomized Trial | 1 2 Pet food has evolved from a primary focus on meeting basic nutritional requirements toward health-oriented formulations with more explicit functional roles. | 3 | Vuthisopon Sujira (2026) | Advances in Functional Pet Food Research: Health-Driven Ingredients, Nutritional Targets and Evidence-Based Claims |
| Fish Oil Dry Eye Randomized Trial | MGD can arise due to numerous extrinsic and intrinsic factors that drive changes in meibum quality or obstruction of gland orifices and can result in tear film instability, hyperosmolarity, epithelial damage and downstream ocular surface inflammation. | 3 | Cooper JM (2026) | Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review. |
| Fish Oil Dry Eye Randomized Trial | Meibomian gland dysfunction (MGD) is a leading cause of non-aqueous deficient dry eye disease. | 3 | Cooper JM (2026) | Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review. |
| Fish Oil Dry Eye Randomized Trial | Meibomian glands are responsible for the production of meibum, a lipid-rich secretion that coats the surface of the tear film, inhibiting evaporation of the underlying aqueous tear fluid. | 3 | Cooper JM (2026) | Pharmacological, Natural and Emerging Therapies for Meibomian Gland Dysfunction: A Review. |
Source documents